Roundtable Discussion- Manufacturing Innovations to Improve Robustness of T cell Therapies

Time: 6:00 pm
day: Day 1 – Track C – Evening


  • Measures to increase success rates and manufacturing yields of genetically modified T cells
  • Reviewing current and future strategies to manufacture autologous products, reduce variability, increase success rates and reduce cost and turn-around times